Brigitte Lampo is a Belgian national with over 30 years of experience in clinical research and operations management. She currently holds a temporary position as Functional Head of Country Clinical Site Operations in the United States for Amgen, where she has worked for over 15 years in various senior management roles overseeing clinical studies in multiple countries. She holds two Master of Science degrees from Ghent University in Belgium and is fluent in Dutch, French, and English with good German skills.

1. Brigitte Lampo
Kattestraat, 28
2811 Hombeek
Tel: +32 15 34 74 00
Mobile: + 32 475 71 77 84
I. Personal Data
Place and date of birth: Gent, 23 March 1965
Marital Status: Married, 2 children
Nationality: Belgian
II. Career (in chronological order, most recent function first)
Temporary assignment as Functional Head of the Country Clinical Site
Operations – United States of America
Senior Manager Development Operations – Belgium, Luxemburg,
Netherlands and Israel - Amgen N.V (from March 2014)
Management of the Clinical Site management Team (around 100 people) and all
phase interventional/ observational studies (on average over 70 active studies) in
Belgium, Luxemburg, The Netherlands and Israel. Leading the integration of
study responsibilities from the Netherlands into the Belgian Hub. Member of
multiple workgroups focused on global change initiatives.
Senior Manager Development Operations – Belgium, Luxemburg, Israel
and Turkey - Amgen N.V (from Jan 2013)
Management of the Global Clinical Site management Team (over 75 people) and
all phase interventional/ observational studies (on average over 70 active studies)
in Belgium, Luxemburg, Israel and Turkey. Leading the transition of study
responsibilities from Belgian Hub to South Africa and Turkey, newly created
stand-alone countries for clinical operations.
Senior Manager Development Operations – Belgium, Luxemburg,
Middle East, Africa and Turkey - Amgen N.V (from Sep 2008)
Management of the Global Clinical Site management Team (over 50 people) and
all phase interventional/ observational studies (on average over 70 active studies)
in Belgium, Luxemburg, Israel, South Africa, Turkey and Malta.
Senior Manager Clinical Field Operations – BELUX - Amgen N.V
(from Jan 2006)
Management of the Clinical Development Team and clinical and medical affairs
interventional/ observational studies in Belgium and Luxemburg.
Development Operations Manager – BELUX - Amgen N.V
(from August 2002)
Management of the Clinical Development Team and clinical and medical affairs
clinical studies in Belgium and Luxemburg.
European Clinical Working Group Leader/ Oncology
Bristol Myers Squibb – Pharmaceutical Research Institute
(From January 2002)
Management of several phase 2 and 3 oncology projects
European Clinical Working Group Leader/ Neuroscience
Bristol Myers Squibb – Pharmaceutical Research Institute
(From August 1999)
Management of the European part (4 European/ Intercontinental protocols) of a
worldwide development program with an antipsychotic agent in different
indications ( Acute Schizophrenia (22 countries), Acute Mania ( 15 countries),

2. Recurrence prevention in Bipolar Disorder ( 14 countries), Psychosis in dementia
(10 countries).
Project Manager – Oncology Therapeutics
Quintiles (merged with BRI end 1996, till July 1999)
Project management of multiple projects in oncology.
The project management role involves integration management, scope
management, time management, cost management, quality management,
resource management, communication management and risk management
throughout the lifespan of the projects.
Furthermore involved in client meetings, proposal discussions, staff recruitment,
management of smaller trials, development of financial tracking systems and
project databases.
International Project Manager/ Group Manager Clinical Operations
BRI International (merged with Health Care Research, 1994- 1996)
Coordination of the planning and implementation of a worldwide study (oncology)
in Europe, South Africa and India (170 centers, 37 countries).
Direct responsibility for Western and Eastern Europe, Africa, Middle East and
India (85 sites, 21 countries).
Involved: Responsibility for project maintenance and oversight: project timelines
and resourcing planning, proposal discussions, protocol development, client
contacts, budget management, quality management, set up and coordination of
central radiographic imaging collection and review, investigator meeting
organization, overall oversight of third parties (central lab, drug distribution)
Line management responsibility for 8 internal people.
International Monitoring Coordinator
Health Care Research, Mechelen (1992 – 1995)
Coordination of the planning and implementation of a multi - centre study (CNS)
in Europe, (70 centers, 900 patients).
This role consisted of being the primary contact with sponsor of trial, protocol
and CRF review, coordination of 8 CRA’s, investigator meeting organization and
presentation, responsibility for study logistics, budget, quality and timelines.
Clinical Research Associate
Health Care Research (1991-1993)
Site selection and monitoring of Ph 2 and Ph 3 clinical studies in rheumatology,
neurology and oncology.
Monitoring of sites in Belgium, the Netherlands, Germany, France, Greece and
Portugal.
Scientific collaborator (1989- 1991)
- Ghent University – Faculty of Medicine – Lab for Movement
Analysis (50%)
- Ghent University – Higher Inst. for Physical Education, Lab for
Movement Sciences (50%)
III. Education
Higher education – Ghent University – Belgium
- Master of Science in Rehabilitation Sciences and Physiotherapy,
1988, Ghent University - Magna Cum Laude
- Master of Science in Physical Education and Movement Sciences,
1986, Ghent University - Magna Cum Laude
- Academic Teaching certificate in Physical Education and Movement
Sciences, Faculty of Psychology and Educational Sciences, 1986, Ghent
University, Cum Laude

3. IV. Languages
Dutch: mother tongue French: written and spoken, good
English: written and spoken, good German: written and spoken, fair